RE:RE:RE:RE:RE:RE:RE:New Poll on Shares Represented by this Board It's hard to imagine they haven't been trying to sell NASH to the people who would expect to bankroll it, serious money. Given where we are now you would have to think that has so far essentially failed. If I had $100mil to invest in THTX's NASH program, and I didn't have the emotional and financial baggage of waiting for such a long time for a Ph3 to start, I think I'd rather invest $10mil in a Ph2b that nailed down all that was missing from this clinical program because it's "odd" ( non-cookie-cutter) rather than put $100mil into bankrolling a Ph3 in which there is real blindness on very important things like endpoints. I know there are many, many positives about this program, not least that Loomba likes it, but it seems the market just really doesn't. The alternative is that the company are pathologically bad at telling the story.
If that was the scenario and I was running the company I might tread water on NASH for the time being and wait for cancer to begin reading out and bankroll both on the back of higher expectations from cancer.
I don't think I would think the solution lays in the froth of this bull market.
As things stand the OO is bankrolling the cancer Ph1 and to some extent the new push on sales, if that is all THTX was selling and all Soleus was buying it would look like a more balanced deal.
SPCEO1 wrote: I am hoping that the company can share with Wino what their plan is to get their stock treated more fairly, to engage investors so that we all can reap rewards fromt he good work management and the board have done on the science side, not just the board and management. Achieving a share price that accurately reflects the value the company has created and is comparable to other similiar stocks is a basic job of the board and management. As we have seen, this has not happened with TH and has led to a share offering done on unbelievably bad terms for legacy shareholders and what appears to be nearly complete disengagement from the company from the analytical community as evidenced by the last quarterly conference call. We are saying this is an untenable situation that demands the immediate and strong attention of the leadership of the company as the past failures cannot be tolerated in the future. We are hopeful Wino can lend his expertise in the capital markets to TH leadership and the ultimate plan that is followed will have a much higher chance of success than what has been seen in the past which has been pretty awful. If Wino comes away convinced that this issue is getting the attention it deseves by TH leadership and that the plan they have to address these shortcomings has a decent chance of success, then we can all go back to enjoying your missives about the very intriguinig science TH has as the share price should begin to respond more appropriately, analysts should re-engage with the company and maybe even an effort to engage with retail investors will be put in place.
This is a fixable problem, so it should not be something that blows up into something bigger. Just about every other company out there right now is enjoying greater engagement with investors than TH, so it is not like the roadmap to more success with the share price is hidden from TH's view. If there is a will to fis it, there will be a way. But things have gotten really pretty bad when your quarterly call following very interesting cancer data being presented at the major cancer conference of the year and a new head of Global marketing cannot attract any interest from the analysts. Strong action is needed and it needs to be implemented ASAP.
Shareholders can direct any part of the business any tme they choose as they are the owners of the business. Normally, in a public company setting, there is no need for such intervention. The problem in this case is so extreme and has cost us all such a considerable sum that the owners unfortunately need to inspire the managers to get moving and that is what is happening.
qwerty22 wrote: Sorry I haven't followed this discussion (I don't know I really want to) but.....
People are pissed the SP hasn't gone up. They blame the IR plan. Is the bottom line here that you want transparency on that part of the business? You want the company to go public on who they are talking to, what they are saying and what the feedback is? Or you want to formulate your own plan and force it on the company? It all seems delusional, I don't know why you think shareholders should have direct control of that part of the business anymore than any other part of the business?
Wino115 wrote: I emailed my shares to LT. I'm following today's input and formulating thoughts. Have a few hard appointments I couldn't move around so will be working on this with all the great thoughts being contributed over next few days but don't want to delay.